Epidemiology of Chronic Hepatitis B in Turkey
Author:
Open Access
- 1 June 2018
- journal article
- review article
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 8 (1) , 73-74
Abstract
Hepatitis B virus (HBV) infection is a global public health problem and it is also a major health concern of Turkey. The estimated number of HBV carriers in Turkey is about 3.3 million, with an overall HBV prevalence of 4.57%. Thus, both prevention and therapy of HBV-infected patients are urgent medical need of Turkey. A total of 1,533 among 37,637 patients who were examined at the Department of Gastroenterology, Ankara University School of Medicine were found to be hepatitis B surface antigen (HBsAg) positive (4%). Viral hepatitis treatment is fully reimbursed in Turkey through the national insurance system, which covers all residents across Turkey. How to cite this article: Özkan H. Epidemiology of Chronic Hepatitis B in Turkey. Euroasian J Hepato-Gastroenterol 2018;8(1):73-74.Keywords
This publication has 117 references indexed in Scilit:
- Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop GroupFertility and Sterility, 2012
- Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic reviewBMC Infectious Diseases, 2011
- Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human conditionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Contemporary genetic technologies and female reproductionHuman Reproduction Update, 2011
- Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver DiseaseAmerican Journal of Gastroenterology, 2011
- Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver diseaseBioFactors, 2010
- Increased Caffeine Consumption Is Associated With Reduced Hepatic FibrosisHepatology, 2009
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Fructose consumption as a risk factor for non-alcoholic fatty liver diseaseJournal of Hepatology, 2008
- Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary reportHepatology International, 2008